IL36RN and psoriasis 14, pustular: Recently, inhibition of IL17A by secukinumab has been reported effective for a pediatric GPP patient with Deficiency of Interleukin-36-Receptor Antagonist (DITRA), implying a possible link between IL36RN mutation and Th17 differentiation in DITRA patients [39].